Bruker Corporation (BRKR)
Bruker Corporation Revenues: 405.60M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BRKR Revenues Rankings
| Overall | 71st percentile | 1281 of 4425 |
| Sector | 78th percentile | 180 of 846 in Technology |
| Industry | 83rd percentile | 9 of 56 in Scientific & Technical Instruments |
BRKR Revenues Range, Past 5 Years
| Minimum | 230.50M | Mar 2009 |
| Maximum | 475.10M | Dec 2011 |
| Average | 320.43M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these BRKR related companies
BRKR News
Wells Fargo Starts Bruker (BRKR) at Outperform; Operational Opportunities
May 17, 9:23AM Street Insider
May 17, 9:23AM Street Insider
Bruker Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
May 15, 8:09PM Seeking Alpha
May 15, 8:09PM Seeking Alpha
Needham & Company Downgrades Ultra Clean (UCTT) to Hold; More Cautious Industry Outlook
May 15, 7:34AM Street Insider
May 15, 7:34AM Street Insider
Bruker to Deliver an Ultra-High Mass Resolution 15 Tesla FTMS System for Petroleomics to ECOPETROL S.A. in Colombia
May 14, 7:00AM Business Wire
May 14, 7:00AM Business Wire
Bruker Corporation's Management Hosts Deutsche Bank AG Health Care Conference (Transcript)
May 13, 5:27AM Seeking Alpha
May 13, 5:27AM Seeking Alpha
UBS Maintains a 'Buy' on Bruker (BRKR); Pieces of the Puzzle Fitting Together
May 02, 1:09PM Street Insider
May 02, 1:09PM Street Insider
$BRKR is 5.1% up since open on unusual high volume and 7.5% up since close.
about 27 days ago by TradeBot
about 27 days ago by TradeBot
Listen to $BRKR Q1 2012 earnings call - live at 09:00 AM, ondemand after - http://stks.co/3bAB
about 27 days ago by earningscast
about 27 days ago by earningscast
$BRKR 200 Day SMA Cross - Price crossed above 200 day SMA (14.3696). Confirmed by volume.
about 33 days ago by TradeIdeasQuant
about 33 days ago by TradeIdeasQuant
$BRKR filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Kxs
about 45 days ago by MarketBrief
about 45 days ago by MarketBrief
Bruker's CEO Presents at Barclays Capital Global Healthcare Conference (Transcript)
Mar 20, 1:11PM Seeking Alpha
Mar 20, 1:11PM Seeking Alpha
Bruker's Management Presents at JPMorgan Global Healthcare Conference (Transcript)
Mar 11, 1:29PM Seeking Alpha
Mar 11, 1:29PM Seeking Alpha
Bruker Corporation to Present at Barclays Capital Global Healthcare Conference
Mar 05, 10:09AM Business Wire
Mar 05, 10:09AM Business Wire
Listen to $BRKR Q4 2011 earnings call - live at 09:00 AM, ondemand after - http://stks.co/2VXq
about 96 days ago by earningscast
about 96 days ago by earningscast
$BRKR New 52 Week Low - Crossed daily lows support. Next support 11.27 from 7/27/2010.
about 189 days ago by TradeIdeasQuant
about 189 days ago by TradeIdeasQuant
$BRKR http://stks.co/T3X BC trade idea for Tuesday 4th October - http://stks.co/T3Y
about 237 days ago by freeswingtrades
about 237 days ago by freeswingtrades
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BRKR | 15.12 | +0.20 | +1.34% | 2.508B |
| BRK.B | 79.25 | -0.55 | -0.69% | 196.25B |
| CBI | 37.12 | -0.53 | -1.41% | 3.628B |
| CBG | 16.38 | -0.01 | -0.06% | 5.372B |
| CBEY | 5.70 | +0.00 | +0.00% | 174.99M |
| CBE | 71.28 | -0.25 | -0.35% | 11.33B |
| CBD | 40.29 | +1.50 | +3.87% | 10.10B |
| CBB | 3.49 | +0.06 | +1.75% | 687.53M |
| CBAN | 5.16 | +0.66 | +14.67% | 43.55M |
| CBAK | 0.699 | +0.01 | +1.45% | 44.61M |
